Rein Therapeutics (RNTX) Shares Issued (2017 - 2026)
Rein Therapeutics (RNTX) posted quarterly Shares Issued of $2.5 million for Q1 2026, up 21.11% year-over-year from $2.0 million in Q1 2025, and down 20.81% quarter-over-quarter from $3.1 million in Q4 2025.
Rein Therapeutics (RNTX) Shares Issued (2017 - 2026) Analysis & Trends
Rein Therapeutics (RNTX) has reported Shares Issued for 10 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued rose 21.11% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (up 21.11% YoY), while the FY2025 annual figure was $3.1 million, changed 0.01% from the prior year.
- Shares Issued retreated to $2.5 million in Q1 2026 per RNTX's latest filing, from $3.1 million in the prior quarter.
- Across five years, Shares Issued topped out at $11.1 million in Q2 2022 and bottomed at $288821.0 in Q4 2022.
- Historically, Shares Issued has averaged $2.6 million across 5 years, with a median of $2.1 million in 2024.
- On a YoY basis, Shares Issued climbed as much as 551.68% in 2023 and fell as far as 95.63% in 2023.
- Rein Therapeutics' Shares Issued stood at $288821.0 in 2022, then jumped by 551.68% to $1.9 million in 2023, then surged by 65.81% to $3.1 million in 2024, then fell by 0.01% to $3.1 million in 2025, then declined by 20.81% to $2.5 million in 2026.
- Business Quant data shows RNTX's Shares Issued at $2.5 million in Q1 2026, $3.1 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Rein Therapeutics | 55.49 Mn | 55.49 Mn | - | 3.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.55 Mn |
| Jun 30, 2026 | 3.55 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 3.07 Mn |
| Jun 30, 2025 | 3.07 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 3.12 Mn |
| Dec 31, 2024 | 3.12 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 1.88 Mn |
| Mar 31, 2024 | 1.88 Mn |